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D
K Shoemark and SJ Alley recently launched
interesting thoughts on how Alzheimer disease
may relate to the oral microbiota. Their paper
The Microbiome and Disease: Reviewing the Links between
the Oral Microbiome, Aging and Alzheimer Disease was
published in J Alzheimers Dis 2015; 43: 72538. A
commentary to the paper is given here:
Alzheimer disease (AD) affects old age. It represents a
one in four risk in Europe for people more than 80 years
old. This currently costs approximately $15 billion in the
UK and $183 billion in the US respectively per year.
With increasing age our bacterial load increases and the
immune defense wanes in favor of the more primitive
innate immunity. Bacteria may influence how we age. Some
of them can trigger damaging host responses. Important
in this interplay is a possible weakening of the bloodbrain
barrier (BBL) by predisposing polymorphisms, e.g. in
Ephrin Type-A Receptor (Epha 1). The latter is a gene asso-
ciated with AD risk. Increased circulating TNFa response
may also help bacteria or their lipopolysaccharide to gain
access to the brain by weakening the BBL. Here they may
trigger neuropathology (amyloid plaques) and change brain
function. The oral epithelium releases increased TNFa and
IL1b when the environmental conditions become more
anaerobic. Levels of TNFa, the production ability of which
is retained throughout life, increase under inflammatory
conditions, e.g. in the AD brain where an inflammatory
response occurs. Periodontitis, dentures and bridges tend
to increase both inflammation and the oral load of anaer-
obes. Particularly periodontitis provides an excellent habitat
for anaerobes (treponemes, Porphyromonas gingivalis,
Fusobacterium nucleatum, Prevotella intermedia), which
are the oral bacteria so far most closely, associated with
AD. An association between tooth loss in early to middle
life in twins and nuns suggested that bacterial overgrowth
can be involved in a sub-group of AD patients, and a
clinical trial with the systemic antibiotics doxycycline
and rifampicin reported beneficial effects slowing down
cognitive decline.
The mouth can be a place for low-grade mucosal
inflammation (mucositis) that can aggravate when saliva
flow is reduced due to age, inactivity or drug side
effects. Furthermore, immune-tolerant bacteria (commen-
sals) may reach the circulation and affect host cell
behavior.
Olfactory ensheathing cells (OECs) can engulf bacteria
and migrate towards sites with TNFa produced by
astrocytes  a sub-type of microglia. OECs help bacteria
to follow nerves into the brain (Trojan horse). Infected
phagocytes also help recognized CNS pathogens such as
Escherichia coli, group B Streptococcus and S. pneumoniae
to enter the brain. The original task of OECs however, is
to prevent invasion of bacteria via the oronasal route.
Interestingly, the odds ratio for women with anosmia was
as high as 9.7 for late onset AD. Oral anaerobes tracking
up the olfactory nerve may possibly destroy it. Neurode-
generation in AD11 mice (develop brain damages com-
mon with human AD) was delayed when the mice were
raised under sterile conditions.
The findings listed may indicate that anaerobic oral
bacteria have a role in some cases of AD. This possibility
should be further elucidated. It would be important to
examine if modification of the oral microbiome through
improved oral hygiene habits could be effective in slowing
down the disease progression of AD.
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